DE69218816D1 - N-acetyl-cysteine Derivate enthaltende pharmazeutische Zusammensetzung zur Behandlung von Katarakt - Google Patents

N-acetyl-cysteine Derivate enthaltende pharmazeutische Zusammensetzung zur Behandlung von Katarakt

Info

Publication number
DE69218816D1
DE69218816D1 DE69218816T DE69218816T DE69218816D1 DE 69218816 D1 DE69218816 D1 DE 69218816D1 DE 69218816 T DE69218816 T DE 69218816T DE 69218816 T DE69218816 T DE 69218816T DE 69218816 D1 DE69218816 D1 DE 69218816D1
Authority
DE
Germany
Prior art keywords
acetyl
treatment
cataract
pharmaceutical composition
composition containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69218816T
Other languages
English (en)
Other versions
DE69218816T2 (de
Inventor
Francesco Santangelo
Giorgio Bertolini
Franco Pellacini
Luciano Soldati
Annibale Gazzaniga
Cesare Casagrande
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zambon SpA
Original Assignee
Zambon SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon SpA filed Critical Zambon SpA
Publication of DE69218816D1 publication Critical patent/DE69218816D1/de
Application granted granted Critical
Publication of DE69218816T2 publication Critical patent/DE69218816T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/265—Esters, e.g. nitroglycerine, selenocyanates of carbonic, thiocarbonic, or thiocarboxylic acids, e.g. thioacetic acid, xanthogenic acid, trithiocarbonic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE69218816T 1991-02-21 1992-02-05 N-acetyl-cysteine Derivate enthaltende pharmazeutische Zusammensetzung zur Behandlung von Katarakt Expired - Fee Related DE69218816T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI910456A IT1249047B (it) 1991-02-21 1991-02-21 Composizione farmaceutica per il trattamento della cataratta

Publications (2)

Publication Number Publication Date
DE69218816D1 true DE69218816D1 (de) 1997-05-15
DE69218816T2 DE69218816T2 (de) 1997-07-17

Family

ID=11358690

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69218816T Expired - Fee Related DE69218816T2 (de) 1991-02-21 1992-02-05 N-acetyl-cysteine Derivate enthaltende pharmazeutische Zusammensetzung zur Behandlung von Katarakt

Country Status (6)

Country Link
US (1) US5519054A (de)
EP (1) EP0499882B1 (de)
JP (1) JP3457687B2 (de)
AT (1) ATE151288T1 (de)
DE (1) DE69218816T2 (de)
IT (1) IT1249047B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1258781B (it) * 1992-01-16 1996-02-29 Zambon Spa Composizione farmaceutica oftalmica contenente n-acetilcisteina e polivinilalcol
WO1995013827A1 (en) * 1993-11-19 1995-05-26 The University Of Sydney A method for preventing or controlling cataract
US5686450A (en) * 1995-06-07 1997-11-11 Alcon Laboratories, Inc. Use of N,N'-bis(mercaptoacetyl) hydrazine derivatives as anticataract agents
WO1997026879A1 (en) * 1996-01-26 1997-07-31 The United States Of America, Represented By The Secretary, Department Of Health And Human Services, The National Institutes Of Health Hydroxylamine compositions for the prevention or retardation of cataracts
AU3212099A (en) * 1998-03-31 1999-10-18 Johnson & Johnson Consumer Companies, Inc. Method for increasing the permeability of horny human tissue
US6231875B1 (en) 1998-03-31 2001-05-15 Johnson & Johnson Consumer Companies, Inc. Acidified composition for topical treatment of nail and skin conditions
AU7330200A (en) * 1999-08-09 2001-05-10 Webb-Waring Institute For Biomedical Research A method for the treatment of ocular oxidative stress
FR2811550B1 (fr) * 2000-07-11 2003-02-14 Oreal Composition a base de vitamines et de sels mineraux, pour diminuer la chute des cheveux et/ou favoriser la repousse des cheveux
US7829709B1 (en) 2007-08-10 2010-11-09 Marquette University Cysteine prodrugs to treat schizophrenia and drug addiction
US8173809B2 (en) 2008-02-07 2012-05-08 Marquette University Cysteine and cystine prodrugs to treat schizophrenia and reduce drug cravings
WO2013163545A1 (en) * 2012-04-26 2013-10-31 Sentient Lifesciences, Inc. Use of n-acetylcysteine amide in the treatment of disease and injury
WO2018174839A1 (en) * 2017-03-18 2018-09-27 Nguyen Mark Quang Cysteine, n-acetylcysteine and penicillamine prodrugs, pharmaceutical compositions thereof, and methods of use

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR4619M (de) * 1965-02-01 1966-11-28
BE744952A (en) * 1969-01-28 1970-07-27 Bristol Myers Co Treatment to maintain the urinary - passages clear
JPS5592315A (en) * 1979-01-05 1980-07-12 Santen Pharmaceut Co Ltd Remedy for cataract
JPS5649879A (en) * 1979-10-01 1981-05-06 Furukawa Electric Co Ltd Electrically heating furnace
BE901885A (fr) * 1985-03-06 1985-07-01 Bruschettini Srl Composition pharmaceutique sous forme de lotion ophtalmique et son procede de preparation.
US4708965A (en) * 1985-09-16 1987-11-24 Morgan Lee R Method of treating herpes virus infections with N,N'-diacetylcystine and derivatives
DE3784905T2 (de) * 1986-07-07 1993-08-05 Teijin Ltd Gamma-l-glutamyl-l-cysteinethylester und arzneimittel, die dieses als aktives mittel enthalten.
FR2651129B1 (fr) * 1989-08-31 1991-12-13 Bfb Etud Rech Eperimentales Nouveaux derives de cysteine; compositions pharmaceutiques ou cosmetiques en contenant.

Also Published As

Publication number Publication date
US5519054A (en) 1996-05-21
JP3457687B2 (ja) 2003-10-20
EP0499882A1 (de) 1992-08-26
EP0499882B1 (de) 1997-04-09
ITMI910456A1 (it) 1992-08-21
ATE151288T1 (de) 1997-04-15
IT1249047B (it) 1995-02-11
DE69218816T2 (de) 1997-07-17
ITMI910456A0 (it) 1991-02-21
JPH0585933A (ja) 1993-04-06

Similar Documents

Publication Publication Date Title
DK0524781T3 (da) Terapeutiske amider
DE69218816T2 (de) N-acetyl-cysteine Derivate enthaltende pharmazeutische Zusammensetzung zur Behandlung von Katarakt
NO913684L (no) Fremgangsmaate for fremstilling av kalsiumopptaksinhibitorer.
ATE201671T1 (de) Chinolon und acridinon derivate zur behandlung der harninkontinenz
ATE92036T1 (de) Kardiovaskulaer aktive verbindungen.
SE8600658D0 (sv) Novel composition of matter
IL131216A0 (en) Drugs inhibiting progress of pterygium and postoperative recurrence of the same
DE69402004D1 (de) Beta-mercapto-propanamidderivate verwendbar zur Behandlung kardiovaskularer Krankheiten oder Erkrankungen
FI101849B1 (fi) Antimikrobiset koostumukset ja niiden käyttö silmälääkkeiden säilömiseksi ja piilolinssien hoitamiseksi
DE69418110T2 (de) N-Heteroaryl substituierte Propanamid-Derivate brauchbar zur Behandlung cardiovascularer Krankheiten
ATE88176T1 (de) 2-hydroxy-3-aryloxy-propylaminderivate mit kardiovaskulaerer wirkung.
DE69409464T2 (de) Derivate von N-epsilon Alkoxy- oder Alkenoxy-carbonyl-Lysin, ihre Herstellung und Verwendung in kosmetischen, pharmazeutischen, hygienischen und nahrhaften Zusammensetzungen
NO913683D0 (no) Fremgangsmaate for fremstilling av kalsiumopptaksinhibitorer.
NO913685D0 (no) Fremgangsmaate for fremstilling av kalsiumopptaksinhibitorer.
DE69908855D1 (de) 9a, 11b-dehydro Derivative von 9-oxime-3-keto-6-0-methylerythromycin
ATE92037T1 (de) Kardiovaskulaer aktive verbindungen.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee